HIGHFDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets 25 mg 100-count Recall 2025

Zydus Lifesciences and Northstar Rx LLC recall Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottles nationwide in the United States. The recall cites CGMP deviations and the presence of N-nitroso desmethyl chlorpromazine above acceptable intake limits. Consumers should stop using the product and contact the manufacturer or a healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 3, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Zydus Lifesciences, Northstar Rx LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Zydus Lifesciences, Northstar Rx LLC
Product type
Chlorpromazine Hydrochloride Tablets 25 mg
Model numbers
Z305062, Z306324, Z401151, Z401152
UPC codes
16714-047, 16714-048, 16714-049, 16714-050, 16714-051, 16714-047-01, 16714-048-01, 16714-049-01 +2 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 3, 2025

  2. Reported by FDA DRUG

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

About This Product

Chlorpromazine hydrochloride tablets are an older antipsychotic medication used to treat certain psychiatric conditions. They are prescription-only and distributed through healthcare channels.

Why This Is Dangerous

The CGMP deviation allowed nitrosamine impurities at levels above acceptable intake. Nitrosamines can pose cancer risks with long-term exposure.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients may need to switch medications under clinician guidance. Stored or dispensed lots may be recalled from pharmacies.

Practical Guidance

How to identify if yours is affected

  1. Check the bottle label for NDC 16714-048-01
  2. Check for model identifiers: Z305062, Z306324, Z401151, Z401152
  3. Ensure the product is Chlorpromazine Hydrochloride 25 mg 100-count bottle

Where to find product info

NDC on packaging; recall notice on FDA enforcement page and manufacturer communications

What timeline to expect

Refund or replacement processing typically 4-8 weeks after submission of required information

If the manufacturer is unresponsive

  • Document all contact attempts
  • File a consumer safety complaint with FDA if needed
  • Consult your clinician if you rely on this medication for mental health treatment

How to prevent similar issues

  • Verify NDC against recall notices before dispensing
  • Use trusted pharmacies
  • Check CGMP compliance in manufacturing and supplier origin

Documentation advice

Keep packaging, receipts, and correspondence; photograph bottle and label for records

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: Z305062, Z306324, Z401151, Z401152; NDC 16714-048-01; 25 mg, 100-count RX bottles; Rx only; Manufactured by Zydus Lifesciences Ltd., Baddi, India; Manufactured for Northstar Rx LLC, Memphis, TN 38141; Distribution: Nationwide in the USA.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 4 model numbers affected: Z305062, Z306324, Z401151, Z401152
  • Recall status: ACTIVE
  • Hazard level: HIGH

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
Z305062
Z306324
Z401151
Z401152
UPC Codes
16714-047
16714-048
16714-049
+7 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls